Oct. 9 at 3:56 PM
$RVTY: Can Revvity's new diabetes initiative generate positive investor sentiment? 🤔
The T1D early detection program is supported by Sanofi, aiming to push Revvity beyond rare disease markets and into large-scale clinical testing. This strategic move could position RVTY for long-term growth if key regulatory milestones are reached and commercialization succeeds.
Explore the strategic implications. https://www.zacks.com/stock/news/2765697/rvty-collaborates-with-sanofi-for-early-detection-of-type-1-diabetes?cid=sm-stocktwits-2-2765697-body-15407&ADID=SYND_STOCKTWITS_TWEET_2_2765697_BODY_15407